Opportunity

Simpler Grants.gov #HT942526AZRPTrRA

Army Solicits Transformative Alzheimer’s Research Proposals for FY26

Buyer

U.S. Army Medical Research Acquisition Activity

Posted

May 01, 2026

Respond By

September 24, 2026

Identifier

HT942526AZRPTrRA

NAICS

541715

The Dept. of the Army is inviting proposals for the FY26 Alzheimer’s Research Program Transforming Research Award, targeting transformative research in Alzheimer’s disease and related dementias. - Government Buyer: - Dept. of the Army, US Army Medical Research Acquisition Activity (USAMRAA) - Products/Services Requested: - Research services focused on: - Advancing knowledge and validation of risk/protective factors for Alzheimer’s disease - Developing methods, technologies, and strategies to reduce risk and prevent AD/ADRD - Clinical research permitted (excluding clinical trials and animal research) - Preliminary data required for projects enrolling human subjects - Community collaboration required for human subject research - Career Initiation or Transition (CIT) Partnership Option available for collaborative teams - Unique/Notable Requirements: - Projects must address at least one of two focus areas: Risk Factor Knowledge or Risk Reduction Solutions - CIT Partnership Option allows collaborative partnerships, with each PI named on separate awards if funded - Up to four awards anticipated, with a total funding pool of $4,000,000 - Maximum period of performance is three years per award - No specific OEMs or commercial vendors are mentioned; the focus is on scientific research and development.

Description

The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD). Applications must address at least one of the following focus areas: Risk Factor Knowledge or Risk Reduction Solutions. Clinical research is allowed, but clinical trials and animal research are prohibited. Preliminary data and community collaboration for research enrolling human subjects are required. The award includes a Career Initiation or Transition (CIT) Partnership Option for collaborative partnerships.

View original listing